Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder

Registros relacionados

• Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
  por: Catto, J, et al.
  Publicado em: (2007)
• Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
  por: Dhawan, D, et al.
  Publicado em: (2006)
• FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
  por: van Oers, J, et al.
  Publicado em: (2009)
• Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
  por: Yates, DR, et al.
  Publicado em: (2006)
• DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
  por: Catto, J, et al.
  Publicado em: (2006)